furosemide has been researched along with Cochlear Hearing Loss in 36 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study investigated whether hearing loss contributes to dementia in the absence of aging and noise using a mouse model of severe bilateral hearing loss induced by kanamycin (1000 mg/kg) and furosemide (400 mg/kg)." | 4.02 | Sensorineural hearing loss may lead to dementia-related pathological changes in hippocampal neurons. ( Fan, C; Hu, H; Shen, Y; Wang, Q; Xiang, M; Ye, B; Zou, T, 2021) |
| " The risk factors associated with this impairment were higher cumulative doses of furosemide and hypocalcemia." | 3.79 | Hearing status in children with frequently relapsing and steroid resistant nephrotic syndrome. ( Batra, VV; Dubey, NK; Gupta, V; Kapoor, K; Lal, P; Saha, A; Sidhu, TS; Upadhyay, AD, 2013) |
| "Monitoring outcomes of neonates after HLHS surgery revealed unexpected PHL associated with hypoxia and bolus administration of furosemide." | 3.78 | Bilateral sensory permanent hearing loss after palliative hypoplastic left heart syndrome operation. ( Alton, GY; Bork, KT; Joffe, AR; Moddemann, DM; Rebeyka, IM; Robertson, CM; Ross, DB; Sauve, RS; Tawfik, GC, 2012) |
| " The present work reports the consequences on high- vs low-level DPOAEs of three types of cochlear impairments involving OHCs: progressive OHC degeneration of genetic origin in CD1 mice, complete cochlear ischemia in gerbils, and furosemide injection vs ischemia-reperfusion in gerbils." | 3.72 | Physiopathological significance of distortion-product otoacoustic emissions at 2f1-f2 produced by high- versus low-level stimuli. ( Avan, P; Bonfils, P; Gilain, L; Mom, T, 2003) |
| " Dosage or duration of aminoglycosides use did not relate to SNHL." | 2.72 | Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. ( Cheung, PY; Etches, PC; Peliowski, A; Robertson, CM; Tyebkhan, JM, 2006) |
| "The incidence of sensorineural hearing loss (SNHL) was investigated in 68 patients who reached chronic renal failure (CRF) in childhood with the aim of identifying possible risk factors." | 2.68 | Sensorineural hearing loss in patients reaching chronic renal failure in childhood. ( Bianchi, PM; Dello Strologo, L; Mancini, ML; Rizzoni, G; Tieri, L, 1996) |
| "Furosemide is a very commonly used loop diuretic in current clinical practice." | 2.36 | Pathophysiology of furosemide ototoxicity. ( Rybak, LP, 1982) |
| "We conclude that severe sensorineural hearing loss can be induced in mice." | 1.39 | Deafness induction in mice. ( Bremer, HG; Grolman, W; Hendriksen, FG; Jansen, TT; Klis, SF; Topsakal, V, 2013) |
| " A dose-response study identified 200 mg/kg of furosemide as the optimal dose for disrupting the stria vascularis and opening the blood-ear barrier." | 1.37 | Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice. ( Ding, D; Fu, Y; Jiang, H; Li, Y; Salvi, R, 2011) |
| "Furosemide did not cause an additional elevation of the threshold of the auditory nerve brainstem evoked response (ABR) over that induced by the salicylic acid injection." | 1.36 | How are the inner hair cells and auditory nerve fibers activated without the mediation of the outer hair cells and the cochlear amplifier? ( Adelman, C; Sohmer, H; Weinberger, JM, 2010) |
| "(41 vs 43% sensorineural hearing loss respectively)." | 1.29 | [Hearing loss resulting from purulent meningitis in the light of adjuvant dexamethasone therapy]. ( Farkas, Z; Hajdi, G; Hirschberg, J; Katona, G; Nyerges, G, 1993) |
| "The efficacy of L-V therapy for other sensorineural hearing loss was also evaluated." | 1.28 | The efficacy of Lasix-vitamin therapy (L-V therapy) for sudden deafness and other sensorineural hearing loss. ( Konishi, K; Nakai, Y; Yamane, H, 1991) |
| "Thirty-five neonates with sensorineural hearing loss (SNHL), identified by brainstem auditory evoked response (BAER), and 70 matched controls with normal BAERs were studied." | 1.28 | Neonatal sensorineural hearing loss associated with furosemide: a case-control study. ( Brown, DR; Sabo, D; Watchko, JF, 1991) |
| "Sensorineural hearing loss was statistically associated (1) with greater amounts of furosemide administration for longer durations and in combination with aminoglycoside antibiotics and (2) with more episodes of low pH, hypoxemia, or both, higher total bilirubin levels, and substantially lower neonatal status scores." | 1.28 | Neonatal status and hearing loss in high-risk infants. ( Eldredge, L; Salamy, A; Tooley, WH, 1989) |
| "Infants with the diagnosis of persistent fetal circulation were evaluated for hearing loss." | 1.27 | Hearing loss in infants with persistent fetal circulation. ( Hendricks-Muñoz, KD; Walton, JP, 1988) |
| " The systemic and local applications of aminoglycosides and the high dosage of furosemide were the probable ototoxic agents." | 1.27 | [Hearing loss, a complication of antibiotic therapy in severely burned patients]. ( Balogh, D; Bauer, M; Rauchegger, H; Zanon, E, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (19.44) | 18.7374 |
| 1990's | 8 (22.22) | 18.2507 |
| 2000's | 6 (16.67) | 29.6817 |
| 2010's | 13 (36.11) | 24.3611 |
| 2020's | 2 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Behrends, W | 1 |
| Ahrens, D | 1 |
| Bankstahl, JP | 1 |
| Esser, KH | 1 |
| Paasche, G | 1 |
| Lenarz, T | 1 |
| Scheper, V | 1 |
| Košec, A | 1 |
| Kruljac, I | 1 |
| Ajduk, J | 1 |
| Shen, Y | 1 |
| Hu, H | 1 |
| Fan, C | 1 |
| Wang, Q | 1 |
| Zou, T | 1 |
| Ye, B | 1 |
| Xiang, M | 1 |
| Henry, KS | 1 |
| Sayles, M | 1 |
| Hickox, AE | 1 |
| Heinz, MG | 1 |
| Kraft, S | 1 |
| Hsu, C | 1 |
| Brough, DE | 1 |
| Staecker, H | 1 |
| Jansen, TT | 1 |
| Bremer, HG | 1 |
| Topsakal, V | 1 |
| Hendriksen, FG | 2 |
| Klis, SF | 3 |
| Grolman, W | 3 |
| Rhee, CK | 1 |
| He, P | 1 |
| Jung, JY | 1 |
| Ahn, JC | 1 |
| Chung, PS | 1 |
| Lee, MY | 1 |
| Suh, MW | 1 |
| Ramekers, D | 1 |
| Versnel, H | 1 |
| Strahl, SB | 1 |
| Wang, Y | 1 |
| Qiao, L | 1 |
| Chen, Y | 1 |
| Wen, L | 1 |
| Yue, B | 1 |
| Qiu, J | 1 |
| Wu, S | 1 |
| Żak, M | 1 |
| van der Linden, CA | 1 |
| Bezdjian, A | 1 |
| Adelman, C | 1 |
| Weinberger, JM | 1 |
| Sohmer, H | 1 |
| Li, Y | 1 |
| Ding, D | 1 |
| Jiang, H | 1 |
| Fu, Y | 1 |
| Salvi, R | 1 |
| Pienkowski, M | 1 |
| Ulfendahl, M | 1 |
| Robertson, CM | 2 |
| Alton, GY | 1 |
| Bork, KT | 1 |
| Joffe, AR | 1 |
| Tawfik, GC | 1 |
| Sauve, RS | 1 |
| Moddemann, DM | 1 |
| Ross, DB | 1 |
| Rebeyka, IM | 1 |
| Saha, A | 1 |
| Gupta, V | 1 |
| Kapoor, K | 1 |
| Dubey, NK | 1 |
| Lal, P | 1 |
| Sidhu, TS | 1 |
| Batra, VV | 1 |
| Upadhyay, AD | 1 |
| Avan, P | 1 |
| Bonfils, P | 1 |
| Gilain, L | 1 |
| Mom, T | 1 |
| Rais-Bahrami, K | 1 |
| Majd, M | 1 |
| Veszelovszky, E | 1 |
| Short, BL | 1 |
| Tyebkhan, JM | 1 |
| Peliowski, A | 1 |
| Etches, PC | 1 |
| Cheung, PY | 1 |
| Abbasi, AH | 1 |
| Ramadan, R | 1 |
| Hoffman, A | 1 |
| Abassi, Z | 1 |
| Humes, LE | 1 |
| Minowa, Y | 1 |
| Rybak, LP | 1 |
| Shapiro, MJ | 1 |
| Purn, JM | 1 |
| Raskin, C | 1 |
| Schwaber, MK | 1 |
| Garraghty, PE | 1 |
| Kaas, JH | 1 |
| Katona, G | 1 |
| Farkas, Z | 1 |
| Hirschberg, J | 1 |
| Hajdi, G | 1 |
| Nyerges, G | 1 |
| Mancini, ML | 1 |
| Dello Strologo, L | 1 |
| Bianchi, PM | 1 |
| Tieri, L | 1 |
| Rizzoni, G | 1 |
| Borradori, C | 1 |
| Fawer, CL | 1 |
| Buclin, T | 1 |
| Calame, A | 1 |
| Bian, L | 1 |
| Chertoff, ME | 1 |
| Bates, DE | 1 |
| Beaumont, SJ | 1 |
| Baylis, BW | 1 |
| Michel, O | 1 |
| Matthias, R | 1 |
| Walton, JP | 2 |
| Hendricks-Munoz, K | 1 |
| Konishi, K | 1 |
| Nakai, Y | 1 |
| Yamane, H | 1 |
| Brown, DR | 1 |
| Watchko, JF | 1 |
| Sabo, D | 1 |
| Hendricks-Muñoz, KD | 1 |
| Salamy, A | 1 |
| Eldredge, L | 1 |
| Tooley, WH | 1 |
| Bauer, M | 1 |
| Zanon, E | 1 |
| Balogh, D | 1 |
| Rauchegger, H | 1 |
2 reviews available for furosemide and Cochlear Hearing Loss
| Article | Year |
|---|---|
Kidney-ear axis.
Topics: Antineoplastic Agents; Branchio-Oto-Renal Syndrome; Carrier Proteins; Cisplatin; Comorbidity; Diuret | 2007 |
Pathophysiology of furosemide ototoxicity.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cats; Diuretics; Dogs; Drug Synergism; Furosemide; | 1982 |
2 trials available for furosemide and Cochlear Hearing Loss
| Article | Year |
|---|---|
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure.
Topics: Amikacin; Aminoglycosides; Anti-Infective Agents; Audiometry, Pure-Tone; Auditory Threshold; Diureti | 2006 |
Sensorineural hearing loss in patients reaching chronic renal failure in childhood.
Topics: Acoustic Impedance Tests; Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Audiometry, Pur | 1996 |
32 other studies available for furosemide and Cochlear Hearing Loss
| Article | Year |
|---|---|
Refinement of systemic guinea pig deafening in hearing research: Sensorineural hearing loss induced by co-administration of kanamycin and furosemide via the leg veins.
Topics: Animals; Disease Models, Animal; Furosemide; Guinea Pigs; Hair Cells, Auditory; Hearing; Hearing Los | 2023 |
Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma.
Topics: Adult; Audiometry, Pure-Tone; Bromocriptine; Cochlear Diseases; Diuretics; Furosemide; Glucocorticoi | 2019 |
Sensorineural hearing loss may lead to dementia-related pathological changes in hippocampal neurons.
Topics: Animals; Dementia; Female; Furosemide; Hearing Loss, Sensorineural; Hippocampus; Inflammation Mediat | 2021 |
Divergent Auditory Nerve Encoding Deficits Between Two Common Etiologies of Sensorineural Hearing Loss.
Topics: Animals; Auditory Perception; Auditory Threshold; Chinchilla; Cochlear Nerve; Disease Models, Animal | 2019 |
Atoh1 induces auditory hair cell recovery in mice after ototoxic injury.
Topics: Animals; Anti-Bacterial Agents; Basic Helix-Loop-Helix Transcription Factors; Cochlear Diseases; Diu | 2013 |
Deafness induction in mice.
Topics: Animals; Disease Models, Animal; Diuretics; Furosemide; Hair Cells, Auditory; Hearing Loss, Sensorin | 2013 |
Effect of low-level laser treatment on cochlea hair-cell recovery after ototoxic hearing loss.
Topics: Animals; Ear Canal; Furosemide; Gentamicins; Hair Cells, Auditory; Hearing Loss, Sensorineural; Lase | 2013 |
Recovery characteristics of the electrically stimulated auditory nerve in deafened guinea pigs: relation to neuronal status.
Topics: Animals; Auditory Perception; Cochlear Implantation; Cochlear Nerve; Disease Models, Animal; Electri | 2015 |
Establishment of a model of cochlear lesions in rats to study potential gene therapy for sensorineural hearing loss.
Topics: Adenoviridae; Animals; Axons; Cell Death; Disease Models, Animal; Furosemide; Gene Transfer Techniqu | 2015 |
Scar formation in mice deafened with kanamycin and furosemide.
Topics: Animals; Disease Models, Animal; Furosemide; Hair Cells, Auditory; Hearing Loss, Sensorineural; Kana | 2016 |
How are the inner hair cells and auditory nerve fibers activated without the mediation of the outer hair cells and the cochlear amplifier?
Topics: Animals; Anion Transport Proteins; Cochlear Nerve; Disease Models, Animal; Evoked Potentials, Audito | 2010 |
Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.
Topics: Animals; Antineoplastic Agents; Auditory Threshold; Cell Death; Cisplatin; Disease Models, Animal; D | 2011 |
Differential effects of salicylate, quinine, and furosemide on Guinea pig inner and outer hair cell function revealed by the input-output relation of the auditory brainstem response.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; | 2011 |
Bilateral sensory permanent hearing loss after palliative hypoplastic left heart syndrome operation.
Topics: Audiometry; Cardiac Surgical Procedures; Child, Preschool; Diuretics; Furosemide; Hearing Loss, Sens | 2012 |
Hearing status in children with frequently relapsing and steroid resistant nephrotic syndrome.
Topics: Adolescent; Audiometry, Pure-Tone; Auditory Threshold; Biomarkers; Bone Conduction; Calcium; Case-Co | 2013 |
Physiopathological significance of distortion-product otoacoustic emissions at 2f1-f2 produced by high- versus low-level stimuli.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Brain Stem; Cochlea; Deafness; Disease Models, An | 2003 |
Use of furosemide and hearing loss in neonatal intensive care survivors.
Topics: Auditory Threshold; Brain Stem; Deafness; District of Columbia; Diuretics; Female; Furosemide; Heari | 2004 |
Noise-induced hearing loss as influenced by other agents and by some physical characteristics of the individual.
Topics: Acoustic Stimulation; Age Factors; Animals; Ethacrynic Acid; Eye Color; Furosemide; Hearing Loss, No | 1984 |
[Sensorineural hearing impairment by combined administration of aminoglycoside drugs, loop diuretics and an anticancer drug (cisplatin)--an experimental study].
Topics: Animals; Cisplatin; Drug Therapy, Combination; Furosemide; Guinea Pigs; Hearing Loss, Sensorineural; | 1984 |
A study of the effects of cardiopulmonary bypass surgery on auditory function.
Topics: Audiometry, Pure-Tone; Cardiopulmonary Bypass; Female; Furosemide; Hearing Loss, Sensorineural; Huma | 1981 |
Neuroplasticity of the adult primate auditory cortex following cochlear hearing loss.
Topics: Animals; Audiometry, Pure-Tone; Auditory Cortex; Ear, Inner; Evoked Potentials, Auditory, Brain Stem | 1993 |
[Hearing loss resulting from purulent meningitis in the light of adjuvant dexamethasone therapy].
Topics: Chemotherapy, Adjuvant; Child, Preschool; Dexamethasone; Female; Furosemide; Hearing Loss, Sensorine | 1993 |
Risk factors of sensorineural hearing loss in preterm infants.
Topics: Aminoglycosides; Evoked Potentials, Auditory, Brain Stem; Furosemide; Gestational Age; Hearing Loss, | 1997 |
Distinguishing cochlear pathophysiology in 4-aminopyridine and furosemide treated ears using a nonlinear systems identification technique.
Topics: 4-Aminopyridine; Animals; Auditory Threshold; Cochlea; Diuretics; Furosemide; Gerbillinae; Hair Cell | 2001 |
Ototoxicity induced by gentamicin and furosemide.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Diuretics; Drug Synergism; Female; Furosemide; | 2002 |
Effects of prostaglandin E2 on the fluctuating hearing loss in Ménière's disease.
Topics: Adult; Aged; Aged, 80 and over; Audiometry, Pure-Tone; Auditory Threshold; Dinoprostone; Female; Fur | 1992 |
Profile and stability of sensorineural hearing loss in persistent pulmonary hypertension of the newborn.
Topics: Amikacin; Analysis of Variance; Follow-Up Studies; Furosemide; Hearing Loss, Sensorineural; Humans; | 1991 |
The efficacy of Lasix-vitamin therapy (L-V therapy) for sudden deafness and other sensorineural hearing loss.
Topics: Adult; Aged; Drug Combinations; Female; Furosemide; Hearing Loss, Sensorineural; Hearing Loss, Sudde | 1991 |
Neonatal sensorineural hearing loss associated with furosemide: a case-control study.
Topics: Auditory Threshold; Brain Stem; Child, Preschool; Deafness; Evoked Potentials, Auditory, Brain Stem; | 1991 |
Hearing loss in infants with persistent fetal circulation.
Topics: Developmental Disabilities; Furosemide; Hearing Aids; Hearing Loss, Sensorineural; Humans; Infant; I | 1988 |
Neonatal status and hearing loss in high-risk infants.
Topics: Aminoglycosides; Anti-Bacterial Agents; Audiometry, Evoked Response; Bilirubin; Furosemide; Hearing | 1989 |
[Hearing loss, a complication of antibiotic therapy in severely burned patients].
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Burns; Creatinine; Female; Furosemide; Hearing Loss, | 1987 |